Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial copper pool refers to the regulated concentration of copper ions within the mitochondria, which serves as an essential cofactor for cytochrome c oxidase (COX) in the electron transport chain [1]. This pool is maintained by specific transporters and chaperones to prevent the formation of reactive oxygen species while ensuring adequate supply for aerobic respiration [1]. Recent discoveries have highlighted the mitochondrial copper pool as the focal point for cuproptosis, a form of regulated cell death where excess copper binds directly to lipoylated components of the tricarboxylic acid (TCA) cycle, such as dihydrolipoamide S-acetyltransferase (DLAT) [2]. This interaction leads to the aggregation of lipoylated proteins and proteotoxic stress, providing a novel therapeutic vulnerability in cancer cells that rely heavily on mitochondrial metabolism [2, 3]. Pharmacological intervention typically involves copper ionophores to induce cuproptosis or copper chelators to manage overload diseases like Wilson's disease or to limit tumor growth and angiogenesis [4, 5]. [1] Cobine et al. (2021) BBA Mol Cell Res; [2] Tsvetkov et al. (2022) Science; [3] Nagai et al. (2012) Free Radic Biol Med; [4] Brewer (2005) Front Biosci; [5] Lutsenko (2010) Biochem Soc Trans.
Copper ionophores (e.g., elesclomol) facilitate the transport of copper into the mitochondrial matrix to induce cuproptosis via lipoylated protein aggregation [2, 3]. Copper chelators (e.g., tetrathiomolybdate) sequester copper ions to prevent toxicity or inhibit copper-dependent enzymes [4, 5].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial copper pool.